(Q33398162)

26 July 2017

title

Influence of folate pathway polymorphisms on high-dose methotrexate-related toxicity and survival in childhood acute lymphoblastic leukemia (English)

1 reference

26 July 2017

1 reference

1 reference

lymphoblastic leukemia

1 reference

Nina Erčulj

1

1 reference

26 July 2017

Barbara Faganel Kotnik

2

1 reference

26 July 2017

Maruša Debeljak

3

1 reference

26 July 2017

Janez Jazbec

4

1 reference

26 July 2017

Vita Dolžan

5

1 reference

26 July 2017

publication date

3 February 2012

1 reference

26 July 2017

1 reference

26 July 2017

volume

53

1 reference

26 July 2017

issue

6

1 reference

26 July 2017

page(s)

1096-1104

1 reference

Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia.

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.639880

Advances in individual prediction of methotrexate toxicity: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.639880

Pharmacogenetic determinants of outcome in acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.639880

Molecular genetic analysis of the gene encoding the trifunctional enzyme MTHFD (methylenetetrahydrofolate-dehydrogenase, methenyltetrahydrofolate-cyclohydrolase, formyltetrahydrofolate synthetase) in patients with neural tube defects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.639880

The MTHFD1 p.Arg653Gln variant alters enzyme function and increases risk for congenital heart defects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.639880

Role of polymorphisms in MTHFR and MTHFD1 genes in the outcome of childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.639880

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.639880

A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.639880

Pharmacogenetics of outcome in children with acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.639880

Methylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.639880

Association of genetic polymorphism in the folate metabolic pathway with methotrexate pharmacokinetics and toxicity in childhood acute lymphoblastic leukaemia and malignant lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.639880

Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.639880

Polymorphism of the thymidylate synthase gene and risk of relapse in childhood ALL.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.639880

Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.639880

Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.639880

A simple salting out procedure for extracting DNA from human nucleated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.639880

GST polymorphisms and occurrence of second neoplasms after treatment of childhood leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.639880

Genetic determinants of methotrexate treatment in rheumatoid arthritis patients: a study of polymorphisms in the adenosine pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.639880

Genetic determinants of methotrexate toxicity in rheumatoid arthritis patients: a study of polymorphisms affecting methotrexate transport and folate metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.639880

Loss of heterozygosity at the thymidylate synthase (TS) locus on chromosome 18 affects tumor response and survival in individuals heterozygous for a 28-bp polymorphism in the TS gene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.639880

The synergy factor: a statistic to measure interactions in complex diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.639880

High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.639880

Methotrexate-induced side effects are not due to differences in pharmacokinetics in children with Down syndrome and acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.639880

Methotrexate area under the curve is an important outcome predictor in patients with primary CNS lymphoma: A pharmacokinetic-pharmacodynamic analysis from the IELSG no. 20 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.639880

Polymorphisms in folate-related genes: association with side effects of high-dose methotrexate in childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.639880

Effects of methylenetetrahydrofolate reductase gene polymorphisms on toxicities during consolidation therapy in pediatric acute lymphoblastic leukemia in a Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.639880

Relationship between 5,10-methylenetetrahydrofolate reductase C677T gene polymorphism and methotrexate related toxicity in patients with autoimmune diseases receiving folic acid supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.639880

Effects of methylenetetrahydrofolate reductase and reduced folate carrier 1 polymorphisms on high-dose methotrexate-induced toxicities in children with acute lymphoblastic leukemia or lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.639880

Ancestry and pharmacogenetics of antileukemic drug toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.639880

Single nucleotide polymorphism in the 5' tandem repeat sequences of thymidylate synthase gene predicts for response to fluorouracil-based chemotherapy in advanced colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.639880

The C677T mutation in the methylenetetrahydrofolate reductase gene: a genetic risk factor for methotrexate-related elevation of liver enzymes in rheumatoid arthritis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.639880

10.3109/10428194.2011.639880

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference